Athar Parvez Ansari

Athar Parvez Ansari

Auto-generated profile, based on publicly available information

Athar Parvez Ansari

Regional Research Institute of Unani Medicine, Chennai (NABH Accredited), New Delhi, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2020 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Open access
PDF file
AAAthar Parvez Ansari
Athar Parvez Ansari
Since antiquity, the Unani system of medicine has been participating in health care system. Usually, four modes of treatment viz. regimenal therapy, dietotherapy, pharmacotherapy and surgery are applied for the treatment of diseases. Regimenal therapy is an important mode in which the morbid matter present in the body is either dispersed/excreted or its unnecessary production is blocked or its flow is restricted and the diseases are cured by natural healer of the body, consequently bring back the humoural stability. Nearly 30 regimens have been mentioned in classical Unani literature. Commonest regimenal procedures such as fasd (venesection/phlebotomy), hijāma (cupping), ta‘līq al-‘alaq (hirudotherapy/leech therapy), ishāl (purgation), qay’ (emesis), idrār - i-bawl (diuresis), huqna (enema), ta’rīq (diaphoresis), riyādat (exercise), dalk (massage), hammām (bathing), tadhīn (oiling), natūl (irrigation), sakūb (douching/spraying), inkibāb (steam/vapour application), takmīd (fomentation) etc. are usually applied for the management of various ailments. These regimenal procedures are completely based on holistic approach and are potential but needs to be explored scientifically. This review outlines the therapeutic applications of various regimens of regimenal therapy used in Unani medicine.

14 September 2022 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
HAHuzaifa Ansari
Huzaifa Ansari
AAAthar Parvez Ansari
Athar Parvez Ansari
IQIfra Qayoom
Ifra Qayoom
BRBazilah Reshi
Bazilah Reshi
AHAbdul Haseeb
Abdul Haseeb
NANoman Anwar
Noman Anwar
Background: Saqmunia, a resin obtained from the root of Convolvulus scammonia L. is widely used in Unani system of medicine for the treatment of several body ailments. This important medicinal plant is belonging to Convolvulaceae family, and is commonly grown in Mediterranean regions. Purpose of the review: The core objective of this appraisal is to emphasize the different characteristics of Saqmunia (Convolvulus scammonia L.) viz. botanical description, pharmacological and therapeutic properties, folklore uses, temperament, dose, scientific studies, etc, as mentioned in Unani and botanical literature that will be helpful in the rationale use of this botanical drug. Materials and methods: This review was done after going through ample of literature survey of Unani and botanical texts, and published articles related to Saqmunia (Convolvulus scammonia L.). The botanical names of drugs mentioned in this review have been validated through ‘World Flora’ (http://www.worldfloraonline.org). Results: The Unani physicians prescribe Saqmunia for the treatment of skin diseases, chronic headache, bilious fever, conjunctivitis, jaundice, etc. This drug is also added in many compound Unani formulations such as Habb-i-Kotwali, Safoof-i-Suranjan, Habb-i-Banafsha, Ayarij-i-Kabir, Tiryaq-i-Zahab, Habb-i-Saqmunia, Majun-i-Anjeer, etc which are used for various therapeutic purposes. The phytochemical analysis of the root of Convolvulus scammonia L. has been reported that it contains 8% resin along with beta-methyl-esculetin, dihydroxy cinnamic acid, ipuranol, sucrose, reducing sugar, starch, etc. The resin yields glycosides mainly scamonin which is pharmacologically active. Some scientific reports showed that this important medicinal plant possesses certain potential pharmacological activities. The significant anticancer property of aqueous and alkaline extracts of Convolvulus scammonia L. has been identified in mice. Conclusion: Although, the resin of Convolvulus scammonia L. is extensively used in Unani medicine. But, sufficient studies regarding its pharmacognosy, phytochemistry, pharmacology and toxicology are still lacking. Hence, it is suggested that extensive studies by using modern scientific parameters may be carried out to explore the every aspect of this important botanical drug. Keywords: Saqmunia; Convolvulus scammonia L.; Unani medicine; Resin

19 December 2023 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
MBMohd Musaib Bhat
Mohd Musaib Bhat
AAAthar Pervez Ansari
Athar Pervez Ansari
AAAnsar Ahmad
Ansar Ahmad
IQIfra Qayoom
Ifra Qayoom
BRBazilah Majeed Reshi
Bazilah Majeed Reshi
Objectives: In Unani medicine, a comprehensive treatment plan has been delineated to deal with febrile illnesses using herbal drugs along with modified dietetics, which stands as a promising area of research. The present study was aimed at evaluating the antipyretic activity of the HAE of Artemisia absinthium L. whole plant as a standalone and as an adjuvant with barley water in an animal model of pyrexia to validate the age-old Unani principle of the treatment. Methods: The pyrexia was induced in all the groups except the plain control using Brewer’s yeast. Group II did not receive any treatment, while group III received crocin, group IV received HAE of A. absinthium , group V administered Ma al-Sha’ir , and group VI was treated with the HAE of A. absinthium along with Ma al-Sha’ir by oral route. The rectal temperature of each rat was recorded at ‘0’ h, 30 min, 60 min, and 180 min. Results: The mean rectal temperature of group III went down from 101.82±0.20 °F to 100.4±0.57 °F over the period of (0–180) minutes, whereas the mean temperature in group IV went down from 102.45±0.60 °F to 100.14±0.57 °F. The mean rectal temperature of group V decreased from 100.62±0.11 °F to 99.55±0.51 °F, while the mean rectal temperature of group VI went down from 101.95±0.1 °F to 97.7±0.11 °F. Conclusions: It is concluded that the HAE of A. absinthium L. as a standalone and along with Ma al Sha’ir showed excellent antipyretic activity as compared to the standard drug in an animal model.

16 August 2024 in European Journal of Medicinal Plants
Verified
Journal Article
Open access
PDF file
AHAbdul Habib
Abdul Habib
KAKhan Sabiha Arzoo
Khan Sabiha Arzoo
ZMZamal Mariyam
Zamal Mariyam
MAMohd Asif
Mohd Asif
NANoman Anwar
Noman Anwar
AAAthar Parvez Ansari
Athar Parvez Ansari
Background: Cyperus rotundus, an important medicinal plant belonging to the Cyperaceae family, is therapeutically used in many traditional systems of medicine, such as Unani medicine, Ayurveda, Siddha, Homeopathy, Chinese medicine, etc. Aim: The prime goal of this review is to provide a scientific basis and classical references for clinical use and further scientific exploration of Cyperus rotundus. Materials and Methods: This systemic review was carried out after searching Unani classical and other ethnobotanical literature and published research work available on PubMed, SCOPUS, Science Direct, Google Scholar, Research Gate, etc. Results: Cyperus rotundus L. is the accepted botanical name of Su'ad Kūfī, Nagarmotha, or Nutgrass as referred in Unani and other traditional medicines. It is grown in India, China, the Philippines, Thailand, Taiwan, Indonesia, Korea, Vietnam, Malaysia, the Pacific Islands, South America, Africa, the Middle East, North America, Mexico, Australia, New Zealand, and Europe. Usually, the rhizome of this important medicinal plant is therapeutically used for various ailments, including indigestion, constipation, dysentery, neurogenic gastralgia, skin diseases, mental weakness, cardiac weakness, nervine weakness, palpitation, weakness of stomach, flatulence, retention of urine, amenorrhea, dribbling of urine, etc. It contains many important secondary metabolites, including flavonoids, tannins, glycosides, monoterpenes, sesquiterpenes, sitosterol, alkaloids, saponins, terpenoids, essential oils, sugar, protein, amino acids, etc., which have been reported to possess antibacterial, anti-tumour, anticonvulsant, antidiabetic, anti-diarrhoeal, anti-inflammatory, antilipidemic, antimalarial, anti-obesity, antioxidant, hepatoprotective, cardioprotective, and neuroprotective pharmacological activities. Conclusion: It is concluded that abundant bioactive compounds identified and separated from Cyperus rotundus possess potential medicinal values on different systems of the body.

15 July 2021 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
AAAthar Parvez Ansari
Athar Parvez Ansari
SSSumyyah Hasina Sana
Sumyyah Hasina Sana
MDMohammad Younis Dar
Mohammad Younis Dar
PGPankaj Goswami
Pankaj Goswami
NAN. Zaheer Ahmed
N. Zaheer Ahmed
Objectives: To validate the concept of abadāl-i-adwiya (drug substitution) by evaluation of physicochemical standardization and hepatoprotective activity of Aristolochia rotunda & its substitute, Curcuma Zedoaria in albino Wistar rats. Methods: Physicochemical standardization by estimation of moisture content, ash values and extractive values were carried out using standard methods. Hepatotoxicity was induced in albino Wistar rats using CCl 4 1 mL/kg s. c. on alternate day for 14 days. Group I was served as Plain control and Group II as Negative control. Group III was administered silymarin 50 mg/kg p. o. while Group IV received HAE of A. rotunda 89.64 mg/kg p. o., and Group V was administered HAE of C. Zedoaria 45.73 mg/kg p. o. At the end of the study, serum bilirubin, AST (SGOT), ALT (SGPT) and ALP were estimated. The histopathology of liver was also carried out. Results: The physicochemical parameters of both test drugs viz. moisture content, total ash, acid insoluble ash and water soluble ash were found within normal limit. The total serum bilirubin, direct bilirubin, AST (SGOT), ALT (SGPT) levels were significantly decreased in Test groups A and B when compared to the Negative and Standard controls. The microscopic examination of liver collected from animals of Group IV and Group V revealed significant recovery from hepatic toxicity compared to the Negative control. Conclusions: The study experimentation has revealed that C. Zedoaria may be used as a substitute for A. rotunda in the treatment of liver diseases. However, the outcome has to be further corroborated with phytochemical evaluation and clinical trials of both the drugs. Furthermore, the concept of drug substitute in Unani system of medicine is also validated in the light of above study.

15 November 2022 in Journal of Drug Delivery and Therapeutics
Verified
Journal Article
Open access
PDF file
NANoman Anwar
Noman Anwar
NANoor Zaheer Ahmed
Noor Zaheer Ahmed
SBShahida Begum
Shahida Begum
AAAthar Parvez Ansari
Athar Parvez Ansari
AVAmmu Jayanthi Viswanathan
Ammu Jayanthi Viswanathan
Objectives: Anorexia is one among the most prevalent conditions triggering malnutrition, drastic weight loss and serious health issues in people especially older adults. Habb-e-Hilteet is commonly prescribed Unani pharmacopoeial formulation for anorexia. However, no scientific data is available as to its safety and efficacy. The current study assessed the appetite-inducing effect and safety of Habb-e-Hilteet in Ḍu‘f al-Ishtihā (anorexia) patients. Methods: An open prospective clinical trial was carried out in 95 clinically diagnosed anorexia patients of either gender (19-65 yrs old). The study was approved by Institutional ethic committee and conducted in accordance with the GCP guidelines. Habb-e-Hilteet, 1 pill (500mg) was administered orally in patients twice daily for 14 days. The safety of the formulation was assessed by important pathological and biochemical indices and monitoring adverse events. The efficacy was assessed on the basis of improvement in the Simplified Nutritional Appetite Questionnaire (SNAQ) score. Results: Out of 95 patients recruited, 78 completed the trial and 17 patients lost to follow-up. The mean age of patients was 29.8 yrs, with the majority (59.0%) being female. Overall therapeutic response was found to be 96%. A significant (P<0.05) increase in the mean SNAQ score was observed after 7 and 14 days of treatment when compared to baseline. No significant difference before and after treatment was observed in pathological and biochemical indices. No adverse events were reported during the entire study period. Conclusion: The study results indicate that Habb-e-Hilteet could be a viable treatment option for anorexia with no safety concerns. Keywords: Ḍu‘f al-Ishtihā; Buṭlān al-Shahwa; Anorexia; Habb-e-Hilteet; Unani pharmacopoeal formulation.